The transaction should be complete in the second quarter of 2013.
Baxano is in the process of developing the iO-Tome system, a precision facetectomy instrument. Trans1 is looking to expand its focus on minimally invasive lumbar spine treatments and improve its financial profile, according to the release.
More Articles on Devices:
Spine Device Manufacturer NuVasive Posts $2.7M 4Q Loss
ArthroCare SpeedLock Hip Implant Cleared by FDA
5 Orthopedic & Spine Device Company Expansions
